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& Abstract
Introduction: For adequate pain treatment in patients with
cancer, it is important tomonitor and evaluate pain regularly.
Although the numeric rating scale (NRS) is implemented in
hospitals in the Netherlands, pain is still not systematically
registered during outpatient consultations. The aim of this
study was to assess whether home telemonitoring increases
pain registration in medical records of outpatients with
cancer.
Methods: Patients with cancer were included in the inter-
vention group (IG) when they visited the outpatient clinic.
They received a short message service and an interactive voice
response on their mobile phones 3 times a week, asking them
to provide their pain score (NRS). When the reported NRS
pain score was ≥5, a specialized oncology nurse adapted the
pain treatment when necessary. Outcomes were compared to
a control group (CG) without home telemonitoring. In both
groups, medical records were analyzed and data on pain and
analgesics were collected.
Results: In each group, the medical records of 54 patients
were analyzed on 3 consecutive outpatient visits. In the CG,
pain registration or its absence was described in 60 visits
(37.0%). In the IG, pain registration or its absence was
reported in 83 visits (51.2%). Patients in the IG received a
prescription for analgesics significantly more often (36/54
patients [66.6%]) than did patients in the CG (18/54 patients
[33.3%]), P < 0.01).
Conclusion: Home telemonitoring for patients with cancer
significantly increases registration of pain and prescriptions
of analgesics in outpatient medical records. Home telemon-
itoring helps to increase the awareness of pain and its
management. &
Key Words: telemonitoring, cancer pain, registration of
pain, numeric rating scale, pain assessment
INTRODUCTION
Pain is one of the most common and feared symptoms in
patients with cancer. Pain prevalence rates are 39%
after curative treatment; 55% during anticancer treat-
ment; and 66% in advanced, metastatic, or terminal
disease.1 Cancer pain management is frequently subop-
timal, despite effective treatments being available.2
Undertreatment appears to be common and has been
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ascribed to some combination of professional-related
and patient-related factors and system issues, such as
fear of opioids and poor assessment of pain.2–6 Other
barriers included physicians’ reluctance to prescribe
opioids and limitations of oncologists’ knowledge.3,7
To improve the quality of pain treatment in the
Netherlands, a revised multidisciplinary, evidence-based
guideline on the diagnosis and treatment of pain in
patients with cancer was published in 2016.8 A validated
pain assessment tool using the numeric rating scale
(NRS) or VAS was recommended each time the patient
visited the outpatient clinic. Although the NRS and VAS
are implemented in hospitals in the Netherlands, pain is
not yet systematically registered in the outpatients’
medical records because oncologists and nurses do not
register pain regularly during consultations.6
The use of modern communication tools can be
useful for early detection and management of moderate
to severe pain, without the need for face-to-face contact.
Other benefits include improved self-management skills
for patients, fewer hospital visits, and increased patient
satisfaction and compliance with care agreements.9
Patients who used telemonitoring felt closer contact
with doctors and felt better cared for. Monitoring their
own health data gave patients more self-awareness
about their pain.10
Home telemonitoring by means of interactive voice
response (IVR) is such a tool. IVR with or without short
message service (SMS) has been effectively used in health
care in the treatment of asthma11, diabetes mellitus,12,13
and anticoagulant management.14
Pain management is part of the daily work at a pain
center, but not for an oncological outpatient clinic. In
our hospital, the pain center and the outpatient oncol-
ogy department are two separate departments, but there
is good mutual contact. From our pain center, we
wanted to investigate whether home monitoring (man-
aged by the pain center) could increase the registration
of pain in the oncologist’s patient medical record.
We used home telemonitoring with an external
computer database and communicated with the patient
by automatic telephone call. A human computer voice
automatically calls the patient periodically. In case of
pain management, the voice invites the patient to give an
actual NRS pain score. The patient answers by entering
a number between 0 and 10 on his or her mobile phone.
This number is sent back and stored in an external
computer database. In this way, a large group of patients
can be called at the same time without active human
intervention (and time). The effect of home
telemonitoring can be twofold: early detection of
moderate to severe pain and increased adequacy of
patients’ pain treatment.
The aim of this study was to assess whether home
telemonitoring increased registration of pain in medical
records of patients visiting a Dutch teaching hospital.
METHODS
Study Population
An intervention study was performed in a before-and-
after design: (1) before: control group not using home
telemonitoring; (2) after: intervention group using home
telemonitoring. Both patient groups visited the outpa-
tient clinic of hematology and pulmonary oncology of the
Reinier de Graaf Hospital (RdGH), and data regarding
pain in their medical records were analyzed. It was
hypothesized that the use of home telemonitoring would
increase registration of pain in the medical records.
The inclusion criteria for both groups were diagnosis
of cancer, 18 years of age or older, and living at home.
The patients in the intervention group also had to
have access to a mobile phone. Exclusion criteria for the
intervention group were patients not speaking Dutch,
patients who could not handle a mobile phone, and
those with cognitive disorders. The patients in the
control group received usual care.
The Medical Ethical Committee (METC) of Zuid
west Holland (METC protocol number 2017-013)
approved this study. This study was also approved by
the science office of the RdGH. Anonymity of every
patient was guaranteed. Informed consent was not
needed for the control group. The intervention group
gave informed consent with oral and written permission.
Study Procedure
After the first visit with the oncologist or specialized
oncological nurse, the patient received an information
leaflet. After 2 weeks, the nurse practitioner of the pain
center called the patients to invite them to participate.
The patients were informed about what home telemon-
itoring is and how it works. Participation in home
telemonitoring was voluntarily.
Intervention Home Telemonitoring
Home telemonitoring is an automatic computer-based
monitoring system that communicates with the patient
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by SMS and IVR. Our hospital contracted a company
specializing in SMS/IVR messaging (EasyCareSolutions
B.V.).
Each patient received an SMS at 9:25 a.m. to
announce the IVR (Figure 1). The text of the SMS
was: “Good day, Ms./Mr. (family name of the patient).
In a couple of minutes, you will receive a phone call from
our computer asking you to give a pain score.” At 9:30
a.m. the IVR call was made by a male voice: “Good day,
this is an automatic call from the pain center. Please
press hash tag (#) to continue. After the beep, on a scale
from 0 to 10, enter a score for the pain you are
experiencing at this moment. 0 means no pain at all, 10
means the worst pain you can imagine.” After providing
the score, the voice said: “We thank you for your
cooperation. We will hang up the phone.”
The time of the phone call at 9:30 a.m. was chosen to
allow the specialized oncology nurses time to discuss
management of the pain. At 11:30 a.m., an appointment
was set for consultation with the oncologist or nurse
practitioner specializing in pain and palliative care.
During the first month, each patient received an SMS
3 times a week (Monday, Wednesday, and Friday). If the
NRS pain score did not exceed 3 (out of 10) after
2 weeks, the patient was called only once a week, on
Wednesday.
Data Collection
For both groups, patient medical records were examined
from the electronic patient file, and the names were
selected from the consultation list of the oncologist.
Patients were chosen in order of first consultation.
Sociodemographic data (eg, date of birth, gender),
medical data (eg, type of cancer, presence of metastasis),
and pain-related data (eg, pain registration or its
absence, prescription of analgesics, general information
about pain, vague descriptions of symptoms related to
pain) were derived from the medical record.
In the intervention group, the NRS pain scores were
registered in the database (EasyCareSolutions B.V.),
including responses and nonresponses. The database
(managed by the pain center) was a stand-alone
database and was not linked to the electronic medical
records of patients. Home telemonitoring is a secure
system that guarantees patients’ privacy.
When the NRS pain score was 5 or higher, the
computer automatically generated an e-mail to the pain
center. The nurse practitioner of the pain center then
contacted the specialized oncology nurse, supplying the
names of the patients with a high NRS pain score. The
specialized oncology nurse called the patients the same
day to (re)-assess andmanage the pain. The effect of pain
management was evaluated during the next SMS/IVR.
Data Analysis
Data from the control group and intervention group
were extracted from the medical records and imported
and analyzed using SPSS version 21 (IBM Corp.,
Armonk, NY, U.S.A.). Descriptive statistics were
assessed on the pain registration or its absence; NRS
pain scores and prescriptions of analgesics were derived
from the medical records. Mean scores were calculated
and compared with paired t-tests. Differences in pro-
portions were tested with the chi-squared test and
Fisher’s exact test. A P value of <0.05 (2-sided) was
considered statistically significant.
RESULTS
Between September 2016 and December 2016, we
assessed 64 patient records and included 54 patients in
the control group. Between February 2017 and May
2017 we approached 80 patients, of whom 54 were
included in the intervention group (Figure 2).
The sociodemographic data are shown in Table 1. In
the intervention group, significantly more men and more
patients with a pulmonary type of cancer participated
than in the control group. Most patients had breast
cancer or urologic/gynecologic cancer. Patient charac-
teristics, except for gender and pulmonary type of
cancer, were not significantly different between the
groups.
Figure 1. Home telemonitoring. NRS, numeric rating scale; SMS,
short message service.
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Some patients visited the doctor or specialized
oncology nurse less frequently or did not want to
participate in home telemonitoring. In both groups, we
analyzed medical records from the first 3 visits (total of
162 visits). All patients in the intervention group
received an SMS/IVR from the pain center 3 times a
week during the first month. In the beginning, 2 of 54
patients in the intervention group experienced some
technical problems in reporting their pain scores. The
nurse practitioner called the patients to identify the
problems. They did not have enough time to enter an
NRS score on the phone. After lengthening the time to
respond from 4 to 8 seconds, no further difficulties were
reported. After this episode, the rate of response of all
patients was 100% on each SMS/IVR, and all NRS pain
scores were registered in the stand-alone database. Only
NRS scores of 5 or higher were automatically sent to the
pain center and then passed on to the specialized
oncology nurse.
Pain Registration
In the control group, nothing was described about pain
in the medical records in 63% of the visits (Table 2),
including no pain scores. In 37% of the visits, pain and
location were described, but nothing about the intensity
or type of pain. “No pain” or “nonspecific pain” also
was reported. The description in the medical records of
“no pain” could mean that pain management was
adequate or that patients had no pain. The “nonspecific
pain” description varied between “it is bearable”
(n = 11), “less pain” (n = 18), “neuropathic pain”
Figure 2. Flow chart of the study.
Table 1. Patient Characteristics
Characteristics
Control Group (n = 54)
Intervention Group
(n = 54)
n (%) n (%) P value
Gender, male 18 (33.3) 30 (55.6) 0.0327
Age group, years
<45 1 (1.9) 4 (7.4)
45 to 60 22 (40.7) 22 (40.7)
60 to 75 21 (38.8) 18 (33.3)
≥75 10 (18.5) 10 (18.5)
Type of cancer
Colorectal 11 (20.4) 6 (11.1) 0.1916
Breast 16 (29.6) 11 (20.4) 0.3743
Urologic/gynecologic 14 (25.9) 11 (20.4) 0.6488
Upper abdomen 4 (7.4) 9 (16.7) 0.2362
Pulmonary 0 9 (16.7) 0.0027
Hematologic 9 (16.6) 8 (14.7) 1
Presence of metastasis
Yes 24 (44.4) 30 (55.6) 0.336
P values ≤ 0.05 are considered significant.
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(n = 10), and “joint pain” (n = 14). All results between
the visits were not significant.
In the intervention group, in 48.8% of the visits there
was nothing described about pain in the medical records
(see Table 2). In 51.2% of the visits, pain or absence of
pain was documented, among which 10.5% included a
description of the intensity of pain using the NRS/VAS,
compared to 0% in the control group. “No pain” or
“nonspecific pain” also was reported. The “nonspecific
pain” description varied between “it is bearable”
(n = 16), “less pain” (n = 24), “neuropathic pain”
(n = 8), and “joint pain” (n = 10).
The total number of “pain registrations” in the
medical records was higher in the intervention group
(51.2%) compared to the control group (37%;
P = 0.034; see Table 2).
Registration of Analgesics
Registration of analgesics was analyzed per patient
(Table 3). In the intervention group, more patients had a
prescription for analgesics than in the control group (36
vs. 18; P = 0.005). In the control group, 36 of 54
patients did not use pain medication, and for 20 of these
patients pain was not described in the medical record. In
the intervention group, 18 patients did not use any
analgesics, and for 4 of these patients pain was not
described in the medical record. Most patients with a
prescription for analgesics used slow-release opioids.
DISCUSSION
The aim of this intervention study was to evaluate
whether the introduction of home telemonitoring of
NRS pain scores increases the registration of pain and
NRS pain scores in the medical records of oncology
outpatients.
Because we only studied the registration of pain by
the oncologists in the medical records, we did not
include analysis of the NRS pain scores in the stand-
alone database in this article. This study showed that the
rate of registration of pain improved from 37.0% in the
control group to 51.2% in the intervention group.
Documentation of the NRS pain scores increased by 0%
in the control group and by 10.5% in the intervention
group. Registration of analgesics was higher in the
intervention group.
Almost all patients with a prescription for analgesics
used a form of slow-release opioids, with stable plasma
levels that did not affect the background cancer pain.
We assumed that the 9:30 a.m. time of calling did not
affect the time the medication was taken.
In 2015, te Boveldt et al.15 analyzed pain registration
in the medical records of oncology outpatients in 6
Dutch hospitals and found that pain was not systemat-
ically registered. Our analysis of the control group
confirmed this conclusion. Our result of 63.0% of “no
pain registration” in the control group corresponded
with their results of nonacademic hospitals. Despite the
implementation of the first Dutch evidence-based guide-
line “Diagnoses and Pain Management in Cancer
Patients” in 2008, this proportion is still remarkably
high.
In 2015, Besse et al.16 found that home telemonitor-
ing yielded a reliable assessment of pain intensity and
facilitated immediate intervention if patients with
Table 2. Pain Registration in the Medical Records
No. of Visits
Pain Registration
No Pain Registration
Registration of Pain or Its
Absence NRS/VAS Registration
CG IG
CG IG CG IG CG IG
n (%) n (%) n (%) n (%) n (%) n (%)
First visit 54 54 21 (38.9) 27 (50) 0 5 (9.2) 33 (61.1) 22 (40.8)
Second visit 54 54 22 (40.8) 21 (38.9) 0 7 (12.9) 32 (59.2) 27 (50.0)
Third visit 54 54 17 (31.5) 18 (33.3) 0 5 (9.2) 37 (68.5) 30 (55.6)
Total 162 162 60 (37.0) 66 (40.7) 0 17 (10.5) 102 (63.0) 79 (48.8)
CG, control group; IG, intervention group; NRS, numeric rating scale.
Table 3. Registration of Analgesics
Registration
Control (n = 54
patients)
Intervention (n = 54
patients)
Registration of
analgesics
18 36
No registration of
analgesics
36 18
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cancer-related pain needed urgent treatment in the
palliative phase of their disease. They concluded that
there appeared to be no barrier to using home telemon-
itoring. Our study also showed that telemonitoring does
not have any barriers at home, despite the 2 patients
who had easily soluble technical problems in the
beginning.
In 2012, Kim et al.17 found in a randomized con-
trolled trial with outpatients diagnosed with stage IV
advanced solid tumors that standardized pain education
and telemonitoring used by nurse practitioners is an
efficient way to improve pain management in the
outpatient clinic. Although Kim et al. used telemonitor-
ing to measure pain for only 1 week without continu-
ation, their findings were consistent with our results.
Unlike Kim et al., we have continued home telemoni-
toring.
After introducing home telemonitoring, the use of
pain medication increased, probably related to increased
recognition of pain. Our intervention group of 54
patients is small, but with consecutive patients, the
expectation is that pain registration and prescription of
pain medication will increase even more when NRS
scores are linked in the medical records.
An explanation for the increased rate of registration
of NRS pain scores in the medical files in the
intervention group (from 0% to 10.5%) may be that
home telemonitoring helps to increase the awareness
of pain and its management, which has a positive
effect on the treatment of pain, resulting in better
communication about pain between doctors, nurses,
and patients. If NRS pain scores in the database are
directly linked to the medical records, the rate of
registration of the scores will increase to 100%, giving
doctors and specialized oncology nurses insight into
the pain itself and the process of pain treatment. This
will direct more attention to the pain and will
immediately lead to an improvement in pain manage-
ment.
Home telemonitoring can be used as a tool to identify
pain at an early stage, to register pain, and to treat it
more effectively. However, home telemonitoring for
registration of cancer pain is relatively new. The RdGH
is one of the first hospitals in the Netherlands that offers
a home telemonitoring service to this patient group.9
Home telemonitoring facilitates the guidance of patients
with pain and prevents them from having additional
pain in the home situation, consequently improving
their quality of life. It also can be a tool that creates more
contact with the patient, which improves the quality of
care. To the patient it is an additional service in the
treatment of pain.
This is the first intervention study to assess the use of
home telemonitoring with SMS/IVR among patients
with cancer pain. Home telemonitoring helped to
increase the awareness of pain and its management in
patients, nurses, and physicians. Our study confirmed
the findings of the study of te Boveldt et al.15 and the
feasibility study by Besse et al.16 However, this study
had limitations. First, it was restricted to the hematology
and pulmonary oncology department of a Dutch
nonacademic teaching hospital, making it less easy to
extrapolate our results to other departments or hospitals
(eg, university hospitals). Second, we could not make a
distinction between cancer-related pain and non-cancer-
related pain in all medical records because the informa-
tion was not available. Last, in the control group,
patients were consecutively included in the order of
registration at the oncology outpatient clinic. The
differences between both groups were based on coinci-
dence.
Recommendation
Home telemonitoring of pain creates awareness in
patients and healthcare providers. Ideally NRS pain
scores should be automatically registered in an elec-
tronic medical record. When both systems are linked,
the rate of NRS pain score registration will increase to
100%. This allows oncologists and specialized oncology
nurses to see the actual scores directly in the medical
records and consequently improve communication and
assessment of pain. In order to assess the optimal
frequency of SMS/IVR calls, it is important to check the
scores of all patients regularly.
For further implementation of home telemonitoring,
a financial investment for the acquisition of a modern
communication system is necessary. Further research is
required to determine the generalizability and (cost)
effectiveness of the implementation of home telemoni-
toring for this specific patient group.
CONCLUSION
Home telemonitoring for patients with cancer signifi-
cantly increased registrations of pain and prescriptions
of analgesics in the outpatient medical records of a
Dutch teaching hospital. Home telemonitoring helped to
increase the awareness of pain and its management
among patients, nurses, and physicians.
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